Results 141 to 150 of about 53,519 (232)

Daratumumab plus bortezomib and dexamethasone as a bridge to allogeneic transplantation in refractory T-cell lymphoblastic lymphoma. [PDF]

Ann Hematol
Maraglino AME, Sammassimo S, Lolli G, Clemente A, Tabanelli V, Pastano R, Derenzini E.   +6 more
europepmc   +1 more source

Comprehensive view on genetic features, therapeutic modalities and prognostic models in adult T-cell lymphoblastic lymphoma. [PDF]

Blood Sci, 2022
Zou Q, Ma S, Tian X, Cai Q.
europepmc   +1 more source

Role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.

Therapeutics and clinical risk management, 2011
T-cell malignancies have distinct biochemical, immunologic, and clinical features which set them apart from non-T-cell malignancies. In the past, T-cell leukemia portended a worse prognosis than leukemia of B-cell origin. Cure rates have improved with intensification of therapy and advanced understanding of the molecular genetics of T-cell malignancies.
openaire   +1 more source

Advancing In Vivo Chimeric Antigen Receptor T‐Cell Engineering to Accelerate Clinical Translation

MedComm, Volume 7, Issue 10, October 2026.
In vivo CAR‐T cell generation directly engineers endogenous T cells using pre‐manufactured gene delivery vectors that target T cells and deliver CAR‐encoding genetic material. The resulting CAR‐T cells expand in vivo and mediate antigen‐specific cytotoxicity.
Zhenxin Bai, Ming Yi, Shengtao Hu, Dixuan Xue, Luxin Wei, Lifeng Zhang, Zhijun Dai   +6 more
wiley   +1 more source

T-cell differentiation stage block bias confers hypermethylation and mediastinal preference in T-cell lymphoblastic lymphoma. [PDF]

Clin Transl Med
Wang J, Qian B, Yu X, Zhang Y, Zhou C, Yang T, Xia L, Zhang G, Zhang YX, Wang Y, Fang Y.   +10 more
europepmc   +1 more source

Role of TGM2 in T‑cell lymphoblastic lymphoma via regulation of IL‑6/JAK/STAT3 signalling. [PDF]

Mol Med Rep, 2022
Wang Y, Zheng N, Sun T, Zhao H, Chen Y, Liu C.   +5 more
europepmc   +1 more source

Therapeutic Exercise Protocol During Hospitalization in Pediatric Oncohematological Patients: Randomized Clinical Trial

Physiotherapy Research International, Volume 31, Issue 4, October 2026.
ABSTRACT Background Leukemias, lymphomas, and central nervous system tumors are among the most common pediatric cancers and may lead to motor deficits, impaired balance, reduced muscle strength, fatigue, and decreased functional capacity. Early physiotherapy during hospitalization may help prevent inactivity and support functional preservation in this ...
Cintia Freire Carniel, Bruna Cunha de Souza, Henrique Ferreira Leite, Juliana Zangirolami‐Raimundo, Rodrigo Daminello Raimundo   +4 more
wiley   +1 more source

Coexistence of T-Cell Lymphoblastic Lymphoma and Ichthyosis Vulgaris: A Case Report. [PDF]

Case Rep Oncol Med
Kamış ŞÇ, Yağcı B.
europepmc   +1 more source

A case of conjunctival precursor T cell lymphoblastic lymphoma presenting with salmon colored conjunctival mass. [PDF]

Am J Ophthalmol Case Rep, 2022
Sugawara R, Usui Y, Takahashi R, Nagao T, Goto H.   +4 more
europepmc   +1 more source

Cross‐Talk Between Histamine H2 Receptor and Glucocorticoid Receptor: Potential Implications in Acute Myeloid Leukemia Treatment

Pharmacology Research &Perspectives, Volume 14, Issue 5, October 2026.
ABSTRACT This study investigates the impact of histamine H2 receptor activation on glucocorticoid receptor (GR)‐mediated transcriptional activity, as well as its effects on leukemic cell proliferation and chemotherapy resistance. We demonstrate that activation of the histamine H2 receptor by its specific agonist, amthamine, enhances GR transcriptional ...
Valeria Torralba‐Agu, Natalia Fernández, Carina Shayo, Carlos Davio, C. Daniel Zappia, Federico Monczor   +5 more
wiley   +1 more source